NPM1 and acute myeloid leukemia: The bone-marrow niche serves as a critical microenvironment that supports the survival, proliferation, and drug resistance of acute myeloid leukemia (AML) blasts (Figure 3), particularly in subsets with specific genetic aberrations such as NPM1 mutation.